Evidence by cancer type
Metronomic therapy in breast cancer
299 studies and 95 trials indexed. 16 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingPhase 2ChinaNCT06787339Capecitabine in Low Risk Triple Negative Breast CancerFudan University
- RecruitingPhase 2CanadaNCT07631052Capecitabine in ER+/HER2-negative Breast CancerUniversity Health Network, Toronto
- RecruitingPhase 2ChinaNCT07602907Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion StudyZhejiang Cancer Hospital
- RecruitingPhase 2ChinaNCT06839560Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain MetastasisCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 2ChinaNCT06771609Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 3ChinaNCT07467330Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line TreatmentFujian Cancer Hospital
- RecruitingPhase 2United StatesNCT06085742BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerUniversity of Illinois Chicago
- RecruitingNot statedChinaNCT06700382Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBCShu Wang
- RecruitingPhase 2ItalyNCT03971045Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast CancerEuropean Institute of Oncology
- RecruitingPhase 3ChinaNCT05063136Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast CancerHenan Cancer Hospital
- RecruitingPhase 3ChinaNCT03561740A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTientsSun Yat-sen University
- Not yet recruitingNot applicableNCT07589972Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast CancerTianjin Medical University Cancer Institute and Hospital
- Not yet recruitingPhase 2NCT07441486A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast CancerTianjin Medical University Cancer Institute and Hospital
- Not yet recruitingPhase 2NCT07019337Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences
- Not yet recruitingPhase 2NCT06229067Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences
- Not yet recruitingPhase 3ChinaNCT05172518Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast CancerSun Yat-sen University
See all 95 trials for breast cancer in the trial finder
Newest studies
- StudyDrug Deliv Transl Res2026 NovChemotherapeutic efficacy of nano formulation capecitabine@SNPs and gamma radiation: a novel metronomic approach for breast cancer treatment.Ghanim MI, et al.
- StudyMol Carcinog2026 Oct 6Cooperative Modulation of the NF-κB and p53 Pathways by Metronomic Cyclophosphamide and Metformin Inhibits Ehrlich Carcinoma Progression and Enhances Systemic Immunity.Zaki HM, et al.
- StudyCancer Med2026 OctUse of Metronomic Chemotherapy in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Multicenter Study.Laini L, et al.
- ReviewCancers (Basel)2026 Aug 3Predictive Biomarkers of Metronomic Chemotherapy Response in Solid Tumors: Chasing an Elusive Signal.Wysocki PJ, et al.
- StudyCell Biochem Funct2026 AugTherapeutic Efficacy of Metronomic Doxorubicin and Low Dose of Gamma Radiation on Breast Cancer Model.Abdelrahman IY, et al.
- StudyJCO Precis Oncol2026 AugDPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.Schettini F, et al.
- StudyCancers (Basel)2026 Jul 17Adverse Events as a Surrogate of Sufficient Pharmacological Exposure in Metronomic Combination Chemotherapy: Extended Real-World Cohort Analysis of the FulVEC Regimen in Metastatic ER+/HER2- Breast Cancer.Buda-Nowak A, et al.
- StudyInt Immunopharmacol2026 Jun 15Dose-dependent bidirectional effects of gemcitabine in 4 T1 breast tumors are associated with angiogenesis and PMN-MDSC-linked immunosuppression.Chen Y, et al.
- StudyCancer Med2026 JunReal-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes.Zhou H, et al.
- ReviewTransl Cancer Res2026 Apr 30Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review.Li S, et al.
- Clinical trialSignal Transduct Target Ther2026 Apr 15HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial).Wu HL, et al.
- StudyOncologist2026 Apr 10Impact of geriatric covariates on metronomic cyclophosphamide efficacy and tolerance-the CHEMETROLD study.Griffe C, et al.
- StudySci Rep2026 Apr 6A real-world study of oral low-dose metronomic vinorelbine in elderly patients with metastatic triple-negative breast cancer.Li J, et al.
- StudyAnticancer Res2026 AprAnalysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers.Chawla SP, et al.
- StudyNaunyn Schmiedebergs Arch Pharmacol2026 MarEfficacy of fulvestrant and capecitabine as maintenance therapy in patients with HR +/HER2 - metastatic breast cancer benefited from first-line chemotherapy.Liu Q, et al.
- StudyTransl Breast Cancer Res2026The efficacy and safety of metronomic vinorelbine combined with anlotinib in HER2-negative advanced breast cancer: a prospective, single-arm clinical study.Wang X, et al.
- StudyChin Clin Oncol2026 FebThe phase III MECCA study on metronomic chemo-endocrine therapy in advanced breast cancer-the results that so many have been waiting for.Wysocki PJ
- StudyBMC Cancer2026 Jan 20Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study.Cazzaniga ME, et al.
- StudyESMO Real World Data Digit Oncol2026 MarSecond-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.Cazzaniga ME, et al.
- Case reportContemp Oncol (Pozn)2026Myelodysplastic syndrome after maintenance treatment with metronomic cyclophosphamide: weighing prolonged stable disease against late toxicity.Carvalho SN, et al.
- StudyTheranostics2026Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery.Subedi L, et al.
- StudyOncol Res Treat2026Patient-Reported Outcome in Metastatic Breast Cancer and Platinum-Resistant Recurrent Ovarian Cancer Patients Treated with Metronomic Cyclophosphamide ± Methotrexate: PROmetronomic.Krajnak S, et al.
- StudyInt J Mol Sci2025 Dec 22Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids.Ilari A, et al.
- StudyAm J Transl Res2025Early capecitabine metronomic chemotherapy improves patient prognosis and safety in early-stage triple-negative breast cancer.Sun Y, et al.
- StudyChin Clin Oncol2025 DecMetronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option.Narvaez D, et al.
- Phase 3 trialLancet Oncol2025 DecMetronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.Yuan J, et al.
- ReviewCancer Innov2025 DecMetronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens.Liu J, et al.
- StudyMath Biosci2025 NovEmploying nullclines to balance treatment efficacy and neurotoxicity for sustained tumor control.Okereke LC, et al.
- StudyTher Adv Med Oncol2025Metronomic chemotherapy of paclitaxel plus cisplatin in patients with metastatic breast cancer: a target trial emulation study.Li Y, et al.
- Clinical trialBreast2025 OctTremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study.De La Motte Rouge T, et al.
- Randomized trialBreast Cancer Res Treat2025 SepA direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.Brems-Eskildsen AS, et al.
- StudyClin Breast Cancer2025 JunOptimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.Trapani D, et al.
- StudySci Rep2025 May 14Enhancing breast Cancer immunotherapy using gold nanoparticles carrying tumor antigens.Javadi MM, et al.
- StudybioRxiv2025 May 7Closed-loop sonothermogenetic control of CAR T cells for metronomic brain cancer therapy.Zamat A, et al.
- StudybioRxiv2025 May 6Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers.Pedroza DA, et al.
- CommentaryCancers (Basel)2025 Apr 15Adjuvant Metronomic Chemotherapy After Surgery in pT1-T2 N0 M0 HER2-Positive and ER/PR-Positive Breast Cancer Plus Targeted Therapy, Anti-Hormonal Therapy, and Radiotherapy, with or Without Immunotherapy: A New Operational Proposal.Roncati L
- Phase 3 trialJ Clin Oncol2025 Apr 10Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial.Hong RX, et al.
- StudyBreast2025 AprCorrigendum to "Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial" [The Breast 78 (2004) 103795].Larsson F K, et al.
- Clinical trialCancer Res Treat2025 AprCombination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study.Hao C, et al.
- Randomized trialJ Chemother2025 AprCombination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial.Azim HA, et al.
